Health Care & Life Sciences » Pharmaceuticals | Jiangsu Lianhuan Pharmaceutical Co. Ltd.

Jiangsu Lianhuan Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
38,317.50
43,892.90
50,005.80
62,525.70
70,556.50
74,169.80
Depreciation, Depletion & Amortization
14,600.10
19,050.40
20,280.00
23,564.50
25,244.60
22,450.10
Other Funds
11,769.30
-
303,429.00
-
4,913.50
11,433.10
Funds from Operations
56,383.40
57,517.50
63,194.00
84,436.40
93,782.70
106,712
Changes in Working Capital
18,834.70
2,677.00
7,125.50
18,845.60
90,147.00
197,962.20
Net Operating Cash Flow
37,548.70
60,194.50
56,068.50
65,590.80
3,635.70
91,250.20
Capital Expenditures
30,948.00
24,806.50
27,408.80
46,210.80
48,640.40
Sale of Fixed Assets & Businesses
-
-
15.10
4.30
83.70
Purchase/Sale of Investments
11.00
-
230.90
-
43,800.00
Net Investing Cash Flow
30,959.00
24,851.70
32,369.10
44,206.50
4,756.60
Cash Dividends Paid - Total
9,126.00
11,752.50
13,319.50
10,134.50
18,884.00
Issuance/Reduction of Debt, Net
42,000.00
33,500.00
13,000.00
-
9,000.00
Net Financing Cash Flow
21,104.70
45,252.50
277,109.50
10,134.50
32,797.50
Net Change in Cash
27,530.20
9,826.90
301,315.90
11,828.80
34,340.00
Free Cash Flow
6,600.70
35,387.90
28,659.70
19,380.00
45,004.70
Deferred Taxes & Investment Tax Credit
364.40
65.60
1,343.20
699.40
4,045.90
1,341
Net Assets from Acquisitions
-
-
3,146.20
-
-
Other Sources
-
-
-
2,000.00
-
Exchange Rate Effect
164.30
82.90
507.00
579.10
421.60
Other Uses
-
45.20
2,060.00
-
-

About Jiangsu Lianhuan Pharmaceutical Co.

View Profile
Address
No. 21 Wenfeng Road
Yangzhou Jiangsu 225009
China
Employees -
Website http://www.lhpharma.com
Updated 07/08/2019
Jiangsu Lianhuan Pharmaceutical Co., Ltd. engages in the development, manufacture, and sale of chemicals and pharmaceutical products. It offers chemical synthetic drugs, antibiotics, and various preparations and auxiliary raw materials for medical use. The company was founded on February 22, 2000 and is headquartered in Yangzhou, China.